Myelodysplastic Syndrome
Showing NaN - NaN of 71
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in New York (ON 01910.Na)
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- ON 01910.Na
-
New York, New YorkColumbia University Medical Center
Jun 22, 2017
Myelodysplastic Syndrome Trial in New York (ON 01910.Na Concentrate)
Withdrawn
- Myelodysplastic Syndrome
- ON 01910.Na Concentrate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 22, 2017
Myelodysplastic Syndrome Trial in Tampa, New York (ON 01910.Na)
Completed
- Myelodysplastic Syndrome
- ON 01910.Na
-
Tampa, Florida
- +1 more
Jun 22, 2017
Allogeneic Stem Cell Transplant, Leukemia, Non-Hodgkins Trial in New York (cytoreductive regimen followed by a CD34+E- selected
Completed
- Allogeneic Stem Cell Transplant
- +5 more
- cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jan 20, 2017
Myelodysplastic Syndrome Trial in New York (Arsenic Trioxide (Tricenox), Cytarabine)
Completed
- Myelodysplastic Syndrome
- Arsenic Trioxide (Tricenox)
- Cytarabine
-
New York, New YorkWeill Medcial College of Cornell University
Mar 2, 2017
Myelodysplastic Syndrome Trial in New York (Maitake)
Completed
- Myelodysplastic Syndrome
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 11, 2016
Cancer, Leukemia, Myelodysplastic Syndrome Trial in New York (Fludarabine, Cyclophosphamide, Transplantation)
Completed
- Cancer
- +3 more
- Fludarabine, Cyclophosphamide
- Transplantation
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 14, 2016
Hodgkin's Disease, Leukemia, Myelodysplastic Syndrome Trial in New York (Rituximab)
Completed
- Hodgkin's Disease
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 29, 2015
Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma Trial in New York (BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF)
Completed
- Leukemia
- +3 more
- BUSULFAN, MELPHALAN, FLUDARABINE, G-CSF
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Dec 22, 2015
Structural Imaging and Cognitive Functions in Adult Stem Cell
Completed
- Acute Myeloid Leukemia
- +5 more
- MRI and cognitive evaluation
- brain MRI study and a brief neuropsychological evaluation
-
New York, New York
- +1 more
Dec 9, 2015
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
-
Los Angeles, California
- +7 more
Jun 4, 2015
Leukemia, Myelodysplastic Syndrome Trial in New York (ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195)
Completed
- Leukemia
- Myelodysplastic Syndrome
- ACTINIUM-225-LABELED HUMANIZED ANTI-CD33 MONOCLONAL ANTIBODY HuM195
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 24, 2015
Myelodysplastic Syndrome Trial in Worldwide (Siltuximab, Placebo, Best supportive care (BSC))
Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- VCL-CB01
- Phosphate-buffered Saline (PBS)
-
Tucson, Arizona
- +21 more
Jul 31, 2013
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in New York (Mylotarg, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
-
New York, New YorkWeill Medcial College of Cornell University
Jun 17, 2013
Myelodysplastic Syndrome Trial in United States (Ezatiostat Hydrochloride, Lenalidomide (Revlimid®))
Completed
- Myelodysplastic Syndrome
- Ezatiostat Hydrochloride
- Lenalidomide (Revlimid®)
-
Phoenix, Arizona
- +8 more
Jun 4, 2013
Myelodysplastic Syndrome Trial in United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Myelodysplastic Syndrome
- decitabine (5-aza-2'deoxycytidine)
-
Berkeley, California
- +23 more
Jan 22, 2013
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (CT53518)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Los Angeles, California
- +4 more
Mar 23, 2009